CoChat

Plasma Heme Oxygenase-1 Levels Distinguish Latent or Successfully Treated Human Tuberculosis from Active Disease

Open access

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Tuberculosis (TB) is associated with oxidative stress and the induction of host anti-oxidants to counteract this response. Heme oxygenase-1 (HO-1) is a critical promoter of cytoprotection in diverse disease models including mycobacterial infection. Nevertheless, the pattern of expression of HO-1 in human tuberculosis has not been studied. Here, we examine expression of HO-1 in M. tuberculosis-exposed and -infected individuals and test its ability to distinguish active from latent and successfully treated TB cases. In addition, we assess correlations between plasma levels of HO-1 and cytokines closely associated with the immunopathogenesis of TB. METHODS: Cross-sectional and longitudinal analyses of levels of HO-1, acute phase proteins and pro-inflammatory cytokines were performed in plasma samples from individuals with active pulmonary, extra-pulmonary or latent TB infection and healthy controls as part of a prospective cohort study in South India. RESULTS: Systemic levels of HO-1 were dramatically increased in individuals with active pulmonary and extra-pulmonary tuberculosis and particularly those with bilateral lung lesions and elevated bacillary loads in sputum. HO-1 levels effectively discriminated active from latent tuberculosis with higher predictive values than either C-reactive protein or serum amyloid protein. Moreover, there was a marked reduction in HO-1 levels in active TB cases following anti-tuberculous therapy but not in those who failed treatment. Pulmonary TB patients displaying the highest concentrations of HO-1 in plasma exhibited significantly elevated plasma levels of interleukin (IL)-10, interferon (IFN)-γ and IL-17 and diminished levels of tumor necrosis factor (TNF)-α. CONCLUSION: These findings establish HO-1 levels as a potentially useful parameter for distinguishing active from latent or treated pulmonary tuberculosis, that is superior in this respect to the measurement of other acute inflammatory proteins.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0062618

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 HO-1 levels associate with disease severity and sputum positivity in tuberculosis. (A) HO-1 levels were evaluated in plasma samples from 97 individuals with active pulmonary tuberculosis (PTB), 35 with active extra pulmonary tuberculosis (EPTB), 39 with latent M. tuberculosis infection (LTBI) and 40 healthy donors (HD). The samples were collected prior to initiation of anti-tuberculosis treatment (ATT). Kruskal-Wallis test and Dunn’s multiple comparisons were used to evaluate statistical differences between the groups. (B) HO-1 levels were compared between 40 PTB patients with a diagnosis of unilateral lung lesions and 37 patients with bilateral lesions identified by chest radiography. (C) PTB cases were classified according to the presence or absence of the acid fast staining bacilli (AFB) in sputum samples. In (B) and (C), the Mann Whitney test was used for statistical comparisons. (D) PTB cases were stratified according to the quantitative bacillary sputum grade determined by AFB staining. Data was analyzed using the Kruskal-Wallis test with linear trend post-test (left panel) or by Spearman correlation (right panel). In (A), (B), (C) and (D), bars represent median values. (E) Comparison of HO-1 levels pre and post ATT in a subset of patients with PTB for which plasma samples were available (n = 33). Data from 5 patients that failed treatment are also shown. The Wilcoxon matched pairs test was used to evaluate the significance of the effect of ATT on HO-1 values. Tx, treatment. *P<0.05; **P<0.01; ***P<0.001.
Figure 1 HO-1 levels associate with disease severity and sputum positivity in tuberculosis. (A) HO-1 levels were evaluated in plasma samples from 97 individuals with active pulmonary tuberculosis (PTB), 35 with active extra pulmonary tuberculosis (EPTB), 39 with latent M. tuberculosis infection (LTBI) and 40 healthy donors (HD). The samples were collected prior to initiation of anti-tuberculosis treatment (ATT). Kruskal-Wallis test and Dunn’s multiple comparisons were used to evaluate statistical differences between the groups. (B) HO-1 levels were compared between 40 PTB patients with a diagnosis of unilateral lung lesions and 37 patients with bilateral lesions identified by chest radiography. (C) PTB cases were classified according to the presence or absence of the acid fast staining bacilli (AFB) in sputum samples. In (B) and (C), the Mann Whitney test was used for statistical comparisons. (D) PTB cases were stratified according to the quantitative bacillary sputum grade determined by AFB staining. Data was analyzed using the Kruskal-Wallis test with linear trend post-test (left panel) or by Spearman correlation (right panel). In (A), (B), (C) and (D), bars represent median values. (E) Comparison of HO-1 levels pre and post ATT in a subset of patients with PTB for which plasma samples were available (n = 33). Data from 5 patients that failed treatment are also shown. The Wilcoxon matched pairs test was used to evaluate the significance of the effect of ATT on HO-1 values. Tx, treatment. *P<0.05; **P<0.01; ***P<0.001.CC0 · PubMed Central
Figure 2 HO-1 as a candidate marker of active pulmonary tuberculosis. Levels of HO-1, C-reactive protein (CRP) and Serum Amyloid Protein-A (SAA) were compared between individuals with LTBI and active TB (A) or between patients with active EPTB and those with PTB (C) using the Mann Whitney test. The power of each of the three different biomarkers to discriminate the above clinical outcomes as analyzed by ROC curves is illustrated in (B) and (D). Symbols represent individual patients and bars represent median values. In (A) and (C), dotted lines represent median values from healthy donors. AUC, area under the curve; 95%CI, 95% confidence interval.
Figure 2 HO-1 as a candidate marker of active pulmonary tuberculosis. Levels of HO-1, C-reactive protein (CRP) and Serum Amyloid Protein-A (SAA) were compared between individuals with LTBI and active TB (A) or between patients with active EPTB and those with PTB (C) using the Mann Whitney test. The power of each of the three different biomarkers to discriminate the above clinical outcomes as analyzed by ROC curves is illustrated in (B) and (D). Symbols represent individual patients and bars represent median values. In (A) and (C), dotted lines represent median values from healthy donors. AUC, area under the curve; 95%CI, 95% confidence interval.CC0 · PubMed Central
Figure 3 Associations between HO-1 and cytokine levels in active pulmonary tuberculosis. (A) Correlations between plasma HO-1 levels and systemic concentrations of IL-10, TNF-α, IFN-γ and IL-17 in individuals with active pulmonary tuberculosis (n = 97). Dotted lines on the X-axis represent the median value of HO-1 within the group of patients with pulmonary disease, while dotted lines on each Y-axis indicate median values for each cytokine. In (B), the correlations were stratified according to the bacillary load in sputum smears. Gray areas designate the quadrants that include the individuals simultaneously displaying values of HO-1 and cytokines above the medians or in the case of TNF-α below the median. Percentage of individuals within in the gray areas was compared between the groups with different bacillary sputum grades using a chi-square analysis and correlations evaluated using Spearman test.
Figure 3 Associations between HO-1 and cytokine levels in active pulmonary tuberculosis. (A) Correlations between plasma HO-1 levels and systemic concentrations of IL-10, TNF-α, IFN-γ and IL-17 in individuals with active pulmonary tuberculosis (n = 97). Dotted lines on the X-axis represent the median value of HO-1 within the group of patients with pulmonary disease, while dotted lines on each Y-axis indicate median values for each cytokine. In (B), the correlations were stratified according to the bacillary load in sputum smears. Gray areas designate the quadrants that include the individuals simultaneously displaying values of HO-1 and cytokines above the medians or in the case of TNF-α below the median. Percentage of individuals within in the gray areas was compared between the groups with different bacillary sputum grades using a chi-square analysis and correlations evaluated using Spearman test.CC0 · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

See all 71

Metadata

Authors
Andrade, B. B., Pavan Kumar, N., Mayer-Barber, K. D., Barber, D. L., Sridhar, R., Rekha, V. V. B., Jawahar, M. S., Nutman, T. B., Sher, A., & Babu, S.
Affiliations
  • National Institutes of Health (US)
  • National Institute of Research in Tuberculosis (IN)
Corresponding author
Andrade, Bruno B.
Venue
PLoS ONE
Published
2013-05-06
Volume
8
Issue
5
Pages
e62618
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2023691638
Cited by
64
References
30
Citations by year
2026: 1 · 2025: 4 · 2024: 5 · 2023: 1 · 2022: 3 · 2021: 8 · 2020: 6 · 2019: 4 · 2018: 8 · 2017: 3 · 2016: 6 · 2015: 5 · 2014: 10
FWCI
5.08
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, public-domain)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
  • NIRT Institutional Scholarship Repository (National Institute of Research in Tuberculosis) (acceptedVersion)
  • Americanae (AECID Library) (submittedVersion, other-oa)
  • Arca - Repositório Institucional da Fiocruz (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • U.S. Department of Health and Human Services
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases (T32AI007610)
  • NHLBI Division of Intramural Research
Topics
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heme Oxygenase-1 and Carbon Monoxide
  • Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
Keywords
heme oxygenase-1, tuberculosis, latent tuberculosis infection, active tuberculosis, plasma biomarkers, Mycobacterium tuberculosis, oxidative stress, cytokines, IL-10, interferon-gamma, IL-17, TNF-α, C-reactive protein, serum amyloid protein, extrapulmonary tuberculosis, pulmonary tuberculosis, bacillary load
MeSH terms
Acute-Phase Reaction, Adolescent, Adult, Aged, Antitubercular Agents, Diagnosis, Differential, Female, Humans, Male, Middle Aged, Mycobacterium tuberculosis, Prospective Studies, ROC Curve, Sputum, Tuberculosis, Pulmonary, Biomarkers, Case-Control Studies, Cytokines, Treatment Outcome, Heme Oxygenase-1, Young Adult, Latent Tuberculosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Plasma Heme Oxygenase-1 Levels Distinguish Latent or Successfully Treated Human Tuberculosis from Active Disease. https://app.cochat.ai/papers/10.1371/journal.pone.0062618
The paper
Andrade, B. B., Pavan Kumar, N., Mayer-Barber, K. D., Barber, D. L., Sridhar, R., Rekha, V. V. B., Jawahar, M. S., Nutman, T. B., Sher, A., & Babu, S. (2013). Plasma Heme Oxygenase-1 Levels Distinguish Latent or Successfully Treated Human Tuberculosis from Active Disease. PLoS ONE. https://doi.org/10.1371/journal.pone.0062618

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.